Cargando…

Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria

BACKGROUND: Nigeria is ranked in the top five countries for tuberculosis deaths worldwide. This study investigated the mycobacterial agents associated with presumptive clinical pulmonary tuberculosis (TB) in Nigeria and evaluated the pattern and frequency of mycobacterial infections over twelve cale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aliyu, Gambo, El-Kamary, Samer S., Abimiku, Alash’le, Brown, Clayton, Tracy, Kathleen, Hungerford, Laura, Blattner, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650061/ https://www.ncbi.nlm.nih.gov/pubmed/23671669 http://dx.doi.org/10.1371/journal.pone.0063170

Ejemplares similares

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2013)

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2014)

Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa
por: Aliyu, Gambo, et al.
Publicado: (2018)

Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges
por: Aliyu, Gambo, et al.
Publicado: (2017)

Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria
por: Aliyu, Ahmad, et al.
Publicado: (2019)

Optimising Mycobacterium tuberculosis detection in resource limited settings
por: Alfred, Nwofor, et al.
Publicado: (2014)

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria
por: Bada, Florence O., et al.
Publicado: (2019)

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2020)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2021)

Immunity in Nigerian women and the effects of pregnancy and infectious disease exposure on fetal immunity
por: Cairo, Cristiana, et al.
Publicado: (2006)

Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria
por: Osawe, Sophia, et al.
Publicado: (2016)

Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study
por: Anaba, Udochisom C., et al.
Publicado: (2019)

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
por: Anude, Chuka J, et al.
Publicado: (2013)

From Intense Rejection to Advocacy: How Muslim Clerics Were Engaged in a Polio Eradication Initiative in Northern Nigeria
por: Nasir, Sani-Gwarzo, et al.
Publicado: (2014)

Preliminary Report on HIV-1 Vaccine Preparedness in Nigeria: Advantages of Recruiting University Students
por: Edubio, Abigail, et al.
Publicado: (2010)

Assuring the quality of diagnostic testing: The future is now
por: Nkengsong, John, et al.
Publicado: (2016)

Textbook of tuberculosis & non-tuberculous mycobacterial diseases
por: Kant, Surya
Publicado: (2021)

Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018)
por: Jahun, Ibrahim, et al.
Publicado: (2022)

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
por: Ndembi, Nicaise, et al.
Publicado: (2020)

Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread
por: Nazziwa, Jamirah, et al.
Publicado: (2020)

Community stakeholder engagement during a vaccine demonstration project in Nigeria: lessons on implementation of the good participatory practice guidelines
por: Folayan, Morenike Oluwatoyin, et al.
Publicado: (2019)

Performance of HIV rapid testing algorithm in Nigeria: Findings from a household-based Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS)
por: Patel, Hetal K., et al.
Publicado: (2022)

Implementing quality assurance for laboratory-based and point-of-care HIV testing in Nigeria
por: Abubakar, Ado, et al.
Publicado: (2016)

The role of connected diagnostics in strengthening regional, national and continental African disease surveillance
por: Gous, Natasha M., et al.
Publicado: (2018)

Factors associated with receipt of a timely infant birth dose of hepatitis B vaccine at a tertiary hospital in North-Central Nigeria
por: Bada, Florence O., et al.
Publicado: (2022)

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria
por: Royal, Walter, et al.
Publicado: (2016)

Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
por: Charurat, Man, et al.
Publicado: (2010)

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017)

Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
por: Kumar, Kartik, et al.
Publicado: (2021)

Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
por: Abdullahi, Adam, et al.
Publicado: (2023)

Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study
por: Jumare, Jibreel, et al.
Publicado: (2023)

A prospective study of non-tuberculous mycobacterial disease among tuberculosis suspects at a tertiary care centre in north India
por: Sharma, Surendra Kumar, et al.
Publicado: (2019)

Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants
por: Kiravu, Agano, et al.
Publicado: (2019)

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study
por: Dakum, Patrick, et al.
Publicado: (2021)

TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection
por: Henrick, Bethany M., et al.
Publicado: (2019)

Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus
por: Dakum, Patrick, et al.
Publicado: (2019)

Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria
por: Avong, Yohanna Kamabi, et al.
Publicado: (2015)

Non-Tuberculous Mycobacterial Diseases in Children
por: Meoli, Aniello, et al.
Publicado: (2020)

Implementing an intensified mentorship approach towards accelerated medical laboratory accreditation in 10 counties in Kenya
por: Musau, Susan K., et al.
Publicado: (2022)

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial
por: Claassen, Cassidy W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a0fs9c6s9upnq85igpcljqa5fc